Tech Company Financing Transactions
OrthoAccel Technologies Funding Round
OrthoAccel Technologies, based in Bellaire, secured $4.1 million from S3 Ventures.
Transaction Overview
Company Name
Announced On
9/30/2010
Transaction Type
Venture Equity
Amount
$4,133,000
Round
Undisclosed
Investors
S3 Ventures (Brian Smith)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6575 West Loop South 200
Bellaire, TX 77401
USA
Bellaire, TX 77401
USA
Phone
Website
Email Address
Overview
The AcceleDent System is currently in a randomized controlled clinical trial at the University of Texas Health Science Center in San Antonio. This trial was enrolled under an Investigational Device Exemption.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Lowe
Chief Financial Officer
Kelly Enos
Chief Operating Officer
Jeff Layton
VP - Marketing
Kathleen Malaspina
VP - Sales
Doug Bukaty
Browse more venture capital transactions:
Prev: 9/30/2010: Andro Diagnostics venture capital transaction
Next: 9/30/2010: Crystal IS venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs